利用Hypo-RESOLVE队列估算低血糖暴露后结局风险:对胰岛素临床试验汇总数据的二次分析
该研究汇总84项试验、39373例1型或2型糖尿病患者数据,采用时间更新Cox回归分析低血糖暴露与死亡、心血管疾病、神经病变、肾病、视网膜病变和抑郁等结局的关联;1型和2型糖尿病中累积低血糖暴露与多种不良结局风险升高相关,且关联不限于需要他人协助的严重低血糖,未发现风险突然加剧的阈值。
要点
- 1型糖尿病中任何级别低血糖累积暴露与神经病变、肾病、视网膜病变和抑郁风险升高相关,风险比1.55至2.81。
- 2型糖尿病中任何级别低血糖累积暴露与死亡、急性心血管疾病、肾病、视网膜病变和抑郁风险升高相关,风险比2.35至3.00。
- 1型和2型糖尿病中,过去10天内任何低血糖与死亡、急性心血管疾病和视网膜病变相关,率比1.32至2.68。
核心结论
- 这些数据与低血糖和糖尿病多个身体系统不良事件风险增加相关一致,且这些关联不限于需要协助的严重低血糖。
研究设计与样本
- 研究汇总84项临床试验、39373例参与者的数据,按糖尿病类型分别进行分析。
- 采用时间更新Cox回归模型,调整年龄、性别、糖尿病病程和HbA1c,评估结局与低血糖累积暴露及过去10天内任何低血糖暴露的关联。
- 暴露包括任何低血糖发作及按严重程度分级(1级、2级和3级)的发作,随后进一步调整更广泛的潜在混杂因素。
- 连续结局的个体内变化以中位数40.4周(1型糖尿病)和26周(2型糖尿病)总结。
主要发现
- 1型糖尿病中,最大调整分析显示任何级别低血糖累积暴露与神经病变、肾病、视网膜病变和抑郁风险升高相关,风险比范围为1.55(p=0.002)至2.81(p=0.002);单独分析1级发作时方向相似,但仅抑郁显著。
- 2型糖尿病中,任何级别低血糖累积暴露与死亡、急性心血管疾病、肾病、视网膜病变和抑郁风险升高相关,风险比范围为2.35(p<0.0001)至3.00(p<0.0001);单独分析1级发作时这些关联仍显著。
- 1型和2型糖尿病中,过去10天内任何类型低血糖与死亡、急性心血管疾病和视网膜病变相关,率比范围为1.32(p=0.017)至2.68(p<0.0001);按低血糖级别单独分析时,这些关联的幅度和显著性有所变化。
- 在1级、2级和3级低血糖定义范围内,未发现这些后果风险突然变得明显的阈值证据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Whether hypoglycaemia increases the risk of other adverse outcomes in diabetes remains controversial, especially for hypoglycaemia episodes not requiring assistance from another person. An objective of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo-RESOLVE) project was to create and use a dataset of pooled clinical trials in people with type 1 or type 2 diabetes to examine the association of exposure to all hypoglycaemia episodes across the range of severity with incident event outcomes: death, CVD, neuropathy, kidney disease, retinal disorders and depression. We also examined the change in continuous outcomes that occurred following a hypoglycaemia episode: change in eGFR, HbA1c, blood glucose, blood glucose variability and weight. METHODS: Data from 84 trials with 39,373 participants were pooled. For event outcomes, time-updated Cox regression models adjusted for age, sex, diabetes duration and HbA1c were fitted to assess association between: (1) outcome and cumulative exposure to hypoglycaemia episodes; and (2) outcomes where an acute effect might be expected (i.e. death, acute CVD, retinal disorders) and any hypoglycaemia exposure within the last 10 days. Exposures to any hypoglycaemia episode and to episodes of given severity (levels 1, 2 and 3) were examined. Further adjustment was then made for a wider set of potential confounders. The within-person change in continuous outcomes was also summarised (median of 40.4 weeks for type 1 diabetes and 26 weeks for type 2 diabetes). Analyses were conducted separately by type of diabetes. RESULTS: The maximally adjusted association analysis for type 1 diabetes found that cumulative exposure to hypoglycaemia episodes of any level was associated with higher risks of neuropathy, kidney disease, retinal disorders and depression, with risk ratios ranging from 1.55 (p=0.002) to 2.81 (p=0.002). Associations of a similar direction were found when level 1 episodes were examined separately but were significant for depression only. For type 2 diabetes cumulative exposure to hypoglycaemia episodes of any level was associated with higher risks of death, acute CVD, kidney disease, retinal disorders and depression, with risk ratios ranging from 2.35 (p<0.0001) to 3.00 (p<0.0001). These associations remained significant when level 1 episodes were examined separately. There was evidence of an association between hypoglycaemia episodes of any kind in the previous 10 days and death, acute CVD and retinal disorders in both type 1 and type 2 diabetes, with rate ratios ranging from 1.32 (p=0.017) to 2.68 (p<0.0001). These associations varied in magnitude and significance when examined separately by hypoglycaemia level. Within the range of hypoglycaemia defined by levels 1, 2 and 3, we could not find any evidence of a threshold at which risk of these consequences suddenly became pronounced. CONCLUSIONS/INTERPRETATION: These data are consistent with hypoglycaemia being associated with an increased risk of adverse events across several body systems in diabetes. These associations are not confined to severe hypoglycaemia requiring assistance.
引用
- Mellor J, Kuznetsov D, Heller S, et al. Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia. 2024. PMID: 39037602. doi:10.1007/s00125-024-06225-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。